Effects of long-term administration of recombinant bovine tumor necrosis factor-α on glucose metabolism and growth hormone secretion in steers

American Journal of Veterinary Research

Volumn 62, Issue 5, 2001, Pages 794-798

  Kushibiki, Shiro ^a   Hodate, Koichi ^a,b   Shingu, Hiroyuki ^a   Ueda, Yasuko ^a   Mori, Yasuyuki ^b   Itoh, Takashi ^b   Yokomizo, Yuichi ^b  

^a NATIONAL AGRICULTURAL RESEARCH CENTER FOR TOHOKU REGION   (Japan)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR; INSULIN; RECOMBINANT BOVINE TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CATTLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HYPERINSULINEMIA; INSULIN RESISTANCE; LONG TERM CARE; NONHUMAN;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0035039260     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2001.62.794     Document Type: Article

References (35)

1. Beutler B, Cerami A. The biology of cachectin/TNF primary mediator of the host response. Annu Rev Immunol 1989;7:625-655.
2. Van Der Poll T, RomijinJA, Endert E. et al. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 1991;261:E457-E465.
3. Lohuis JACM, Verheijden JHM, Burvenich C, et al. Pathophysiological effects of endotoxins in ruminants. Vet Q 1988; 10:109-125.
4. Knowles RG, Beevers SJ, Pogson CI. The roles of glucagon, insulin and glucocorticoid hormones in the effects of sublethal doses of endotoxin on glucose homeostasis in rats. Biochem Pharmacol 1986;35:4043-4048.
5. Hotamisligil GS, Spiegelman BM. TNF and the insulin resistance of obesity. Diabetes Mellitus 1996;61:554-560.
6. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992;130:43-52.
7. Kenison DC, Elsasser TH, Fayer R. Tumor necrosis factor as a potential mediator of acute metabolic and hormonal responses to endotoxemia in calves. Am J Vet Res 1991;52:1320-1326.
8. Kushibiki S, Hodate K, Ueda Y, et al. Administration of recombinant bovine tumor necrosis factor affects intermediary metabolism and insulin and growth hormone secretion. J Anim Sci 2000;78:2164-2171.
9. Ohmann HB, Campos M, Snider M, et al. Effect of chronic administration of recombinant bovine tumor necrosis factor to cattle. Vet Pathol 1989;26:462-472.
10. Kushibiki S, Hodate K, Shingu H. Acute phase responses and metabolic changes induced by recombinant bovine tumor necrosis factor-α in calves. Bull Tohoku Natl Agric Exp Stn 2000;96:39-50.
11. Sartin JL, Elsasser TH, Gunter DR, et al. Endocrine modulation of physiological responses to catabolic disease. Domest Animal Endocrinol 1998;15:423-429.
12. Elsasser TH, Caperna TJ, Fayer R. Tumor necrosis factor affects growth hormone secretion by a direct pituitary interaction. Proc Sci Exp Biol Med 1991;198:547-554.
13. Udaka S, Yamagata H. High-level secretion of heterologous protein by Bacillus brevis. Methods Enzymol 1993;217:23-33.
14. Johke T. Effects of TRH on circulating growth hormones, prolactin and triiodothyronine levels in the bovine. Endocrinol Jpn 1978;25:19-26.
15. Miles PDG, Romeo OM, Higo K, et al. TNF-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes 1997;46:1678-1683.
16. Spitzer JJ, Bagby GJ, Meszaros K, et al. Altered control of carbohydrate metabolism in endotoxemia. Prog Clin Biol Res 1989; 286:145-165.
17. Saghizadeh M, Ong JM, Garvey WT, et al. The expression of TNF by human muscle: relationship to insulin resistance. J Clin Invest 1996;97:1111-1116.
18. Kern PA, Saghizadeh M, Bosch RJ, et al. The expression of tumor necrosis factor in human adipose tissue. J Clin Invest 1995;95: 2111-2119.
19. Mizock BA. Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 1995;98:75-84.
20. Hauner H, Petruschke T, Russ M, et al. Effects of tumor necrosis factor on glucose transport and lipid metabolism of newlydifferentiated human fat cells in cell culture. Diabetelogia 1995; 38:764-771.
21. Szalkowski D, White-Carrington S, Berger J, et al. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology 1995;136: 1474-1481.
22. Hotamisligil GS, Peraldi A, Budavari R, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF- and obesity-induced insulin resistance. Science 1996;271:665-668.
23. Kanety H, Feinstein R, Papa MZ, et al. Tumor necrosis factor-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 1995;270:23780-23784.
24. DeFronzo RA, Gunnarsson R, Bjorkman O, et al. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type 2) diabetes mellitus. J Clin invest 1985;76: 149-155.
25. Ciaraldi TP, Carter L, Mudaliar S, et al. Effects of tumor necrosis factor on glucose metabolism in cultured human muscle cells from nondiabetic and type 2 diabetic subjects. Endocrinology 1998;139:4793-4800.
26. Evans DA, Jacobs DO, Wilmore W. Tumor necrosis factor enhances glucose uptake by peripheral tissues. Am J Physiol 1989; 257:R1182-R1189.
27. 12 muscle cells. Am J Physiol 1999;276:E849-E855.
28. Begum N, Ragolia L. Effect of tumor necrosis factor on insulin action in cultured rat skeletal muscle cells. Endocrinology 1996;137:2441-2446.
29. Corbett JA, Sweetland MA, Wang JL, et al. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A 1993;90:1731-1736.
30. Zhang S, Kim KH. TNF inhibits glucose-induced insulin secretion in a pancreatic B-cell line. FEBS Lett 1995;377:237-239.
31. Argiles JM, Lopez-Soriano J, Lopez-Soriano FL. Cytokines and diabetes. Horm Metab Res 1994;26:447-449.
32. Kwon G, Xu G, Marshall CA, et al. Tumor necrosis factor-induced pancreatic beta-cell insulin resistance is mediated by nitric oxide and prevented by 15-deoxy-delta 12,14-prostaglandin J2 and aminoguanidine. J Biol Chem 1999;274:18702-18708.
33. Lang CH, Pollard V, Fan J, et al. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. Am J Physiol 1997;273:R371-R378.
34. Coleman ES, Elsasser TH, Kemppainen RJ, et al. Effect of endotoxin on pituitary hormone secretion in sheep. Neuroendocrinology 1993;58:111-122.
35. Kastin NW, Martin JB. Altered release of growth hormone and thyrotropin induced by endotoxin in the rat. Am J Physiol 1982; 243:E332-E337.